RE: This could be a specific target cohort8 Sep 2021 13:23
Interestingly in a UK/US trial dddd a pharma to delivered far better results in US than they did in the UK, they said that part of it was down to the general well being/diet etc.. conditions in US and selected participants could be more ill in layman terms given that many would have been the generally more severe Beta/delta variants and potentially "sicker", breathlessness does seem to have been more of a focus on activ2 where sng seems to excel .....if at home in the US delivered far better in the US than UK that would be nice.